Over-diagnosis and under-diagnosis of screen- vs non-screen-detected prostate cancers with in men with prostate-specific antigen levels of 2.0

Over-diagnosis and under-diagnosis of screen- vs non-screen-detected prostate cancers with in men with prostate-specific antigen levels of 2.0–10.0 ng/mL

Published:2008-05 Issue:10 Volume:101 Page:1223-1226
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Pelzer Alexandre E.,Colleselli Daniela,Bektic Jasmin,Schaefer Georg,Ongarello Stefano,Schwentner Christian,Aigner Fritz,Mitterberger Michael,Steiner Eberhard,Bartsch Georg,Horninger Wolfgang

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2007.07367.x/fullpdf

Reference19 articles.

1. Cancer Statistics, 2007

2. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening

3. PROSTATE CANCER DETECTION IN MEN WITH PROSTATE SPECIFIC ANTIGEN 4 TO 10 NG/ML USING A COMBINED APPROACH OF CONTRAST ENHANCED COLOR DOPPLER TARGETED AND SYSTEMATIC BIOPSY

4. Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men

5. Under Diagnosis and Over Diagnosis of Prostate Cancer in a Screening Population With Serum PSA 2 to 10 ng/ml

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overdiagnosis across medical disciplines: a scoping review;BMJ Open;2017-12

2. The Effect of Green Tea Consumption on Prostate Cancer Risk and Progression: A Systematic Review;Nutrition and Cancer;2017-02-17

3. Trends in Prostate-specific Antigen Screening, Prostate Biopsies, Urology Visits, and Prostate Cancer Treatments From 2000 to 2012;Urology;2015-09

4. Use of Screening Tests, Diagnosis Wait Times, and Wait-Related Satisfaction in Breast and Prostate Cancer;Current Oncology;2014-06-01

5. Overdiagnosis and Overtreatment of Prostate Cancer;European Urology;2014-06